Alternate Cancer Remedies
run analyses on Krebiozen for Dr. Durovic. On December 5, 1963, all this data (24 pages of it), favorable in the extreme to Krebiozen, was published in the Congressional Record and re- leased to the news media. On all counts, the facts were devastating. Miles Robinson, M.D., who signed this 24-page report, concluded with these words: “Finally, we must firmly keep in mind that the principal objective of the doctors and pa- tients who have observed the effects of Kre- biozen is to secure a fair clinical test for the drug under the auspices and extensive facili- ties of the government, so that the results will be conclusive. It is estimated that such a test would not take more than a few months, nor require over $75,000 of the 454 million dollars spent by the National Cancer Institute on such tests each year. “The NCI tests approximately 24,000 new substances on animals and 100 on humans ev- ery year. Practically all of these substances are highly toxic, and by their very nature offer no real promise in cancer. “Krebiozen represents an entirely new and unique approach and everyone admits it is non- toxic . . It is high time that these people halt the lucrative parade of poisons pouring into can- cer research and into cancer patients, and pay attention to Krebiozen and the unique approach it represents.” In November 1966, Ivy and Durovic and their group were indicted on 49 counts for violations of the FDA Act, mail fraud, making false statements to the government, mislabeling, and conspiracy. Nine months later the case was heard, with 121 government witnesses, 57 defense witnesses, 700 exhibits (literally weighing a ton) and 20,000 pages of court testimony. On January 30-31, 1966, the jury found all parties innocent. Immediately, Durovic left the country. Despite the verdict, in late 1966 federal law prohibited the shipment of Krebiozen across state lines. Ivy was now alone, and so he changed the name from the commercial name, Krebiozen, to Carcalon. His organization was Ivy Cancer Re- search Foundation. He continued to treat patients with the substance, which, by this time, he was deriving from both cow and horse plasma. The battle continued on for years; but, even- tually Krebiozen’s defenders retired, left the coun- try, or died off. And that was the end of that.
we will delay consideration of it until later in this book.
SAMUEL BEALE, M.D., SERGE A. KOROLJOW, M.D., 1950s
Note to researchers: This is an intriguing discovery, and deserves additional study.
Working Summary: It is rather surprising that so many different approaches can provide cancer remission. Because the cancer cell has such a strong craving for sugar, one would not expect that insulin injections would destroy cancer tissue!
Dr. Beale, of Sandwich, Massachusetts, was treating a near-gangrenous infection of the toe in a 63-year-old patient, and found that the patient was slightly diabetic. When he began insulin injections, he found the toe improved dramatically, as well as the diabetes. When the patient’s diet was changed, the insulin was no longer needed, but the toe be- came worse.
Beale began using small doses of insulin for healing ulcers and other serious skin breaks, with no dangerous side effects. Then he began treating cancer cases, ranging from minor skin cancer to cancers of the eye and breast.
It is believed that the reaction caused by the insulin was increased oxidation. As the cell burned more oxygen, it had more energy. Since cancer cells lack oxygen, this burning may some- how have weakened those cells.
Oddly enough, diabetics are no more likely than others to develop cancer, yet they have less insulin.
Several years later, Serge A. Koroljow, M.D., a New Jersey physician, reported on his use of in- sulin in treating cancer (Psychiatric Quarterly, April, 1963). Koroljow reported that, in Germany, insulin is used routinely in the treatment of can- cer.
In Russia, the insulin treatment is used even more extensively. One Russian report described 16 cancer patients treated with insulin. Four recovered completely, 10 had temporary remis- sion of 3-6 months, and 2 showed no change.
According to Koroljow, insulin therapy for cancer is regularly used in Italy, Spain, and South America.
EVANGELOS D. DANOPOULOS, M.D., 1957
Note to researchers: The Danopoulos method has been widely researched already, so it should not be difficult to repro- duce these favorable results.
In the 1950s, another substance (laetrile) was beginning to gain slight attention. Because the con- troversy over it erupted later and continues today,
Working Summary: This was the second of three purified urine factor methods of treating cancer.